ZA757481B - New antihypertensive compounds and method of preparing same - Google Patents

New antihypertensive compounds and method of preparing same

Info

Publication number
ZA757481B
ZA757481B ZA7481A ZA757481A ZA757481B ZA 757481 B ZA757481 B ZA 757481B ZA 7481 A ZA7481 A ZA 7481A ZA 757481 A ZA757481 A ZA 757481A ZA 757481 B ZA757481 B ZA 757481B
Authority
ZA
South Africa
Prior art keywords
preparing same
antihypertensive compounds
new antihypertensive
new
compounds
Prior art date
Application number
ZA7481A
Other languages
English (en)
Inventor
H Petersen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of ZA757481B publication Critical patent/ZA757481B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
ZA7481A 1974-12-20 1975-11-27 New antihypertensive compounds and method of preparing same ZA757481B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB55209/74A GB1489879A (en) 1974-12-20 1974-12-20 N'-cyano-n'-3-pyridylguanidines

Publications (1)

Publication Number Publication Date
ZA757481B true ZA757481B (en) 1977-01-26

Family

ID=10473276

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA7481A ZA757481B (en) 1974-12-20 1975-11-27 New antihypertensive compounds and method of preparing same

Country Status (22)

Country Link
US (2) US4057636A (US20030199744A1-20031023-C00003.png)
JP (1) JPS6028819B2 (US20030199744A1-20031023-C00003.png)
AT (1) AT346357B (US20030199744A1-20031023-C00003.png)
BE (1) BE836885A (US20030199744A1-20031023-C00003.png)
CA (1) CA1067083A (US20030199744A1-20031023-C00003.png)
CH (1) CH618429A5 (US20030199744A1-20031023-C00003.png)
DD (1) DD122529A5 (US20030199744A1-20031023-C00003.png)
DE (2) DE2557438A1 (US20030199744A1-20031023-C00003.png)
DK (1) DK145341C (US20030199744A1-20031023-C00003.png)
ES (1) ES443725A1 (US20030199744A1-20031023-C00003.png)
FI (1) FI60560C (US20030199744A1-20031023-C00003.png)
FR (1) FR2294703A1 (US20030199744A1-20031023-C00003.png)
GB (1) GB1489879A (US20030199744A1-20031023-C00003.png)
IE (1) IE42141B1 (US20030199744A1-20031023-C00003.png)
IT (1) IT1062213B (US20030199744A1-20031023-C00003.png)
LU (1) LU74071A1 (US20030199744A1-20031023-C00003.png)
NL (1) NL184109C (US20030199744A1-20031023-C00003.png)
PH (1) PH12506A (US20030199744A1-20031023-C00003.png)
SE (1) SE424637B (US20030199744A1-20031023-C00003.png)
SU (1) SU683615A3 (US20030199744A1-20031023-C00003.png)
YU (1) YU39754B (US20030199744A1-20031023-C00003.png)
ZA (1) ZA757481B (US20030199744A1-20031023-C00003.png)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562066A (en) * 1978-11-03 1980-05-10 Toshihiko Okamoto N-(2-substituted-4-pyridyl)-urea and thio urea, their preparation and plant growth regulator
US4490533A (en) * 1980-12-22 1984-12-25 Merck & Co., Inc. Aminoalkyl pyridine derivatives
IE52935B1 (en) * 1981-04-15 1988-04-13 Leo Pharm Prod Ltd Pharmaceutical preparation
IE54196B1 (en) * 1981-09-10 1989-07-19 Leo Pharm Prod Ltd Chemical compounds
DK58983D0 (da) * 1983-02-11 1983-02-11 Leo Pharm Prod Ltd Farmaceutisk praeparat
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
US4617311A (en) * 1985-05-17 1986-10-14 Eli Lilly And Company Antiasthmatic method
DE3887591T2 (de) * 1987-07-07 1994-05-19 Beecham Group Plc Pinacidil zur Behandlung von pulmonaler Hypertonie oder Rechtsversagen.
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation
GB8801318D0 (en) * 1988-01-21 1988-02-17 Leo Pharm Prod Ltd Pharmaceutical preparations
US5244664A (en) * 1988-01-21 1993-09-14 Leo Pharmaceutical Products Ltd. Topical preparation for treatment of alopecia
WO1989010757A1 (en) * 1988-05-10 1989-11-16 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemis New ophthalmic preparation for treating glaucoma
US5011837A (en) * 1988-08-09 1991-04-30 E. R. Squibb & Sons, Inc. Aryl cyanoguanidines: potassium channel activators and method of making same
NZ229828A (en) * 1988-08-09 1992-03-26 Squibb & Sons Inc Aryl cyanoguanidine derivatives and pharmaceutical compositions
US5278169A (en) * 1988-08-09 1994-01-11 E. R. Squibb & Sons, Inc. Method of treating or prevention of fibrillation of the heart
JP2884412B2 (ja) * 1988-10-21 1999-04-19 日本バイエルアグロケム株式会社 殺虫性シアノ化合物
US5264445A (en) * 1989-02-03 1993-11-23 Eli Lilly And Company (-)-N"-cyano-N-3-pyridyl-N'-1,2,2-trimethylpropylguanidine
CA2009074C (en) * 1989-02-03 1999-07-27 David Wayne Robertson Improvements in and relating to guanidine derivatives
EP0407346A3 (en) * 1989-07-07 1991-10-02 Ciba-Geigy Ag Aminopyridines
US5006523A (en) * 1989-10-26 1991-04-09 E. R. Squibb & Sons, Inc. Antiarrhythmic agents: aryl cyanoguanidine potassium channel blockers
US5217982A (en) * 1990-09-25 1993-06-08 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive properties
JPH05294935A (ja) * 1991-03-15 1993-11-09 Green Cross Corp:The アミノピリジン系化合物
US5371086A (en) * 1991-03-15 1994-12-06 The Green Cross Corporation Aminopyridine compounds
FR2677019B1 (fr) * 1991-05-27 1994-11-25 Pf Medicament Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
US5593993A (en) * 1991-08-02 1997-01-14 Medivir Ab Method for inhibition of HIV related viruses
IL102548A (en) * 1991-08-02 1998-08-16 Medivir Ab Use of painting derivatives in the preparation of drugs for VIH inhibition and treatment of SDIA and new compounds
CA2123312A1 (en) * 1991-12-23 1993-07-08 Pharmacia & Upjohn Company A potent drug for treatment of erectile dysfunction
US5262419A (en) * 1992-06-11 1993-11-16 E. R. Squibb & Sons, Inc. Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
WO1994004499A1 (en) * 1992-08-13 1994-03-03 The Upjohn Company Cyanoguanidines as potassium channel blockers
GB9219472D0 (en) * 1992-09-15 1992-10-28 Leo Pharm Prod Ltd Chemical compounds
JPH06228100A (ja) * 1992-12-07 1994-08-16 Green Cross Corp:The 光学活性アミノピリジン誘導体およびその用途
ATE176905T1 (de) * 1993-06-11 1999-03-15 Upjohn Co Pyrimidine-cyanoguanidine als kaliumkanalblocker
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
US5633374A (en) * 1993-11-26 1997-05-27 The Upjohn Company Pyrimidine, cyanoguanidines as K-channel blockers
ES2116726T3 (es) * 1994-01-28 1998-07-16 Upjohn Co Cianoguanidinas utilizadas como bloqueadores del canal k.
US5525742A (en) * 1994-06-10 1996-06-11 The Upjohn Company Azidophenylcyanoguanidines as photoaffinity probes
US5856449A (en) * 1994-11-17 1999-01-05 Pharmacia & Upjohn Company Protein affecting KATP channels
WO1998006399A1 (en) * 1996-08-15 1998-02-19 Smithkline Beecham Corporation Il-8 receptor antagonists
US5972894A (en) * 1997-08-07 1999-10-26 Cytran, Inc. Peptides having potassium channel opener activity
US6013668A (en) * 1997-08-13 2000-01-11 Bristol-Myers Squibb Company Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl) amino]methyl]amino]benzonitrile
US6458835B2 (en) 1997-08-13 2002-10-01 Bristol-Myers Squibb Company Method of inhibiting or treating chemotherapy-induced hair loss
WO1999011621A2 (en) * 1997-09-03 1999-03-11 American Home Products Corporation Thiourea for increasing hdl-cholesterol levels, which are useful as anti-atherosclerotic agents
US6255323B1 (en) 1999-04-09 2001-07-03 Shionogi Bioresearch Corp. Cyanoguanidine compounds
GB9908410D0 (en) 1999-04-13 1999-06-09 Pfizer Ltd Pyridines
AU4841700A (en) * 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
US6645968B2 (en) 1999-08-03 2003-11-11 Abbott Laboratories Potassium channel openers
KR20050071598A (ko) 2002-10-24 2005-07-07 메르크 파텐트 게엠베하 라프-키나아제 억제제로서의 메틸렌 우레아 유도체
US9296697B2 (en) * 2005-08-24 2016-03-29 Abbott Laboratories Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-HT5-receptors
US20070250567A1 (en) * 2006-04-20 2007-10-25 Graham Philip R System and method for controlling a telepresence system
US20110009446A1 (en) * 2008-01-11 2011-01-13 Nektar Therapeutics Oligomer-guanidine class conjugates
DK2649048T3 (en) * 2010-12-09 2016-07-25 Radikal Therapeutics Inc MULTIFUNCTIONAL NITROXIDE DERIVATIVES AND USE THEREOF
WO2021044413A1 (en) * 2019-09-03 2021-03-11 Salzman Group Ltd. Atp-regulated potassium channel openers comprising guanidine and uses thereof
WO2023176554A1 (ja) * 2022-03-14 2023-09-21 国立大学法人東北大学 認知機能改善剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3036083A (en) * 1959-05-15 1962-05-22 Ciba Geigy Corp Certain 2-pyridyl lower alkyl guanidines
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines

Also Published As

Publication number Publication date
BE836885A (fr) 1976-06-21
NL7514852A (nl) 1976-06-22
DK145341B (da) 1982-11-01
IE42141L (en) 1976-06-20
CA1067083A (en) 1979-11-27
USRE31244E (en) 1983-05-17
YU39754B (en) 1985-04-30
NL184109B (nl) 1988-11-16
FR2294703A1 (fr) 1976-07-16
NL184109C (nl) 1989-04-17
IE42141B1 (en) 1980-06-04
SU683615A3 (ru) 1979-08-30
DK572975A (da) 1976-06-21
SE7514153L (sv) 1976-06-21
FI753520A (US20030199744A1-20031023-C00003.png) 1976-06-21
GB1489879A (en) 1977-10-26
YU316275A (en) 1982-02-28
FR2294703B1 (US20030199744A1-20031023-C00003.png) 1980-06-27
FI60560C (fi) 1982-02-10
DK145341C (da) 1983-03-28
DE2557438C2 (US20030199744A1-20031023-C00003.png) 1989-01-05
JPS5186474A (US20030199744A1-20031023-C00003.png) 1976-07-29
IT1062213B (it) 1983-09-20
LU74071A1 (US20030199744A1-20031023-C00003.png) 1976-11-11
PH12506A (en) 1979-04-18
AU8712775A (en) 1977-06-09
DE2560633C2 (US20030199744A1-20031023-C00003.png) 1988-09-08
US4057636A (en) 1977-11-08
JPS6028819B2 (ja) 1985-07-06
ES443725A1 (es) 1977-04-16
AT346357B (de) 1978-11-10
CH618429A5 (US20030199744A1-20031023-C00003.png) 1980-07-31
FI60560B (fi) 1981-10-30
DE2557438A1 (de) 1976-06-24
DD122529A5 (US20030199744A1-20031023-C00003.png) 1976-10-12
ATA936075A (de) 1978-03-15
SE424637B (sv) 1982-08-02

Similar Documents

Publication Publication Date Title
ZA757481B (en) New antihypertensive compounds and method of preparing same
YU186175A (en) Method of interconnecting edges
BG27744A3 (en) Method of obtaining of hynazolin derivatives
BG24813A4 (en) Method of obtaining 2-tetrahydrofurfuryl-6,7-benzomorphanes and salts thereof
BG24812A3 (en) Method of obtaining 8-thiomethylergolins
PH11250A (en) (-aryl-4)substituted piperidinoalkanol derivatives,composition and method of use thereof
JPS51128343A (en) Selfflubrication heattresisting materials and method of manufacture
BG24542A3 (en) Method of preparing carbonylaldiminomethanphosphonates
JPS51149291A (en) Preparation method of imidazolinylaminoquinoxaline and quinazolines
CS191882B2 (en) Method of preparing 7-methoxy-6-thia-tetracycline
IL46580A0 (en) Self-adhesive tiles for dry-tiling and method of preparing the same
BG29573A3 (en) Method of obtaining of benzodiazepin derivatives
BG23901A3 (en) Method of preparing pyridobenzodiazepinones
BG29427A3 (en) Method for obtaining of l- 6- dioxy- 5- hudroxytetracycline
GR59201B (en) Preparation method of 8,8-disubstituted-6-methylergolines and related compounds
BG27915A3 (en) Method of obtaining of moenomyzin
GR59205B (en) New preparation method of methoxy-2-benzamides derivative
BG23900A3 (en) Method of preparing 2-carbalcoxy-amino-benzimidazolyl-5(6)-sulfoacid phenylates
JPS51125082A (en) Preparation method of 77 substitutedd88aminomethyll isoflavon derivatives
ZA75416B (en) Ureidotetralin compounds and method of use
ZA753247B (en) (d1)-13-substituted sulfinyl-prostaglandinlike compounds and methods of making
JPS51125089A (en) Preparation method of piperazinopyrimidine derivatives
IL48565A0 (en) Method of preparation of 3-methylenecephams
JPS51125088A (en) Preparation method of new benzhydryloxyyalkylamine derivatives
BG24403A3 (en) Method of preparing 2-nitrobenzaldehyde